These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Evaluation of a new paraffin-reactive CD7 T-cell deletion marker and a polymerase chain reaction-based T-cell receptor gene rearrangement assay: implications for diagnosis of mycosis fungoides in community clinical practice. Ormsby A; Bergfeld WF; Tubbs RR; Hsi ED J Am Acad Dermatol; 2001 Sep; 45(3):405-13. PubMed ID: 11511839 [TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical studies using monoclonal antibodies on lymph nodes from patients with mycosis fungoides and Sézary's syndrome. Willemze R; Scheffer E; Meijer CJ Am J Pathol; 1985 Jul; 120(1):46-54. PubMed ID: 3893151 [TBL] [Abstract][Full Text] [Related]
26. Cytologic evaluation of lymphadenopathy associated with mycosis fungoides and Sezary syndrome: role of immunophenotypic and molecular ancillary studies. Pai RK; Mullins FM; Kim YH; Kong CS Cancer; 2008 Oct; 114(5):323-32. PubMed ID: 18798522 [TBL] [Abstract][Full Text] [Related]
27. Clinical characteristics and course of CD8+ cytotoxic variant of mycosis fungoides: a case series of seven patients. Nikolaou VA; Papadavid E; Katsambas A; Stratigos AJ; Marinos L; Anagnostou D; Antoniou C Br J Dermatol; 2009 Oct; 161(4):826-30. PubMed ID: 19558552 [TBL] [Abstract][Full Text] [Related]
28. The relevance of peripheral blood T-helper 1 and 2 cytokine pattern in the evaluation of patients with mycosis fungoides and Sézary syndrome. Papadavid E; Economidou J; Psarra A; Kapsimali V; Mantzana V; Antoniou C; Limas K; Stratigos A; Stavrianeas N; Avgerinou G; Katsambas A Br J Dermatol; 2003 Apr; 148(4):709-18. PubMed ID: 12752128 [TBL] [Abstract][Full Text] [Related]
29. O6-alkylguanine-DNA alkyltransferase in cutaneous T-cell lymphoma: implications for treatment with alkylating agents. Dolan ME; McRae BL; Ferries-Rowe E; Belanich M; van Seventer GA; Guitart J; Pezen D; Kuzel TM; Yarosh DB Clin Cancer Res; 1999 Aug; 5(8):2059-64. PubMed ID: 10473086 [TBL] [Abstract][Full Text] [Related]
30. Pagetoid reticulosis (Woringer-Kolopp disease): an immunophenotypic, molecular, and clinicopathologic study. Haghighi B; Smoller BR; LeBoit PE; Warnke RA; Sander CA; Kohler S Mod Pathol; 2000 May; 13(5):502-10. PubMed ID: 10824921 [TBL] [Abstract][Full Text] [Related]
31. Comparative flow immunophenotypic features of the inflammatory infiltrates of Hodgkin lymphoma and lymphoid hyperplasia. Hudnall SD; Betancourt E; Barnhart E; Patel J Cytometry B Clin Cytom; 2008 Jan; 74(1):1-8. PubMed ID: 18061945 [TBL] [Abstract][Full Text] [Related]
32. Mycosis fungoides with a CD56+ immunophenotype. Wain EM; Orchard GE; Mayou S; Atherton DJ; Misch KJ; Russell-Jones R J Am Acad Dermatol; 2005 Jul; 53(1):158-63. PubMed ID: 15965442 [TBL] [Abstract][Full Text] [Related]
33. Expression of chemokines and chemokine receptors in cutaneous CD30+ lymphoproliferative disorders. Yamaguchi T; Ohshima K; Karube K; Kawano R; Nakayama J; Suzumiya J; Kikuchi M Br J Dermatol; 2006 May; 154(5):904-9. PubMed ID: 16634894 [TBL] [Abstract][Full Text] [Related]
34. Dermal infiltrates of cutaneous T-cell lymphomas with epidermotropism but not other cutaneous lymphomas are abundant with langerin⁺ dendritic cells. Der-Petrossian M; Valencak J; Jonak C; Klosner G; Dani T; Müllauer L; Pehamberger H; Knobler R; Trautinger F J Eur Acad Dermatol Venereol; 2011 Aug; 25(8):922-7. PubMed ID: 21054571 [TBL] [Abstract][Full Text] [Related]
35. Clinicopathologic, immunophenotypic and ultrastructrual analyses of ATLL patients with cutaneous involvement. Wang C; Yao Z; Liao J; Luo Y; Ma Y; Chen G; Zhu W Chin Med J (Engl); 1999 May; 112(5):461-5. PubMed ID: 11593520 [TBL] [Abstract][Full Text] [Related]
36. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases]. Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665 [TBL] [Abstract][Full Text] [Related]
37. Expression of cytotoxic proteins by neoplastic T cells in mycosis fungoides increases with progression from plaque stage to tumor stage disease. Vermeer MH; Geelen FA; Kummer JA; Meijer CJ; Willemze R Am J Pathol; 1999 Apr; 154(4):1203-10. PubMed ID: 10233858 [TBL] [Abstract][Full Text] [Related]
38. A patient with clinicopathologic features of small plaque parapsoriasis presenting later with plaque-stage mycosis fungoides: report of a case and comparative retrospective study of 27 cases of "nonprogressive" small plaque parapsoriasis. Belousova IE; Vanecek T; Samtsov AV; Michal M; Kazakov DV J Am Acad Dermatol; 2008 Sep; 59(3):474-82. PubMed ID: 18694680 [TBL] [Abstract][Full Text] [Related]
39. Utility of flow cytometry immunophenotyping and DNA ploidy studies for diagnosis and characterization of blood involvement in CD4+ Sézary's syndrome. Lima M; Almeida J; dos Anjos Teixeira M; Queiros ML; Santos AH; Fonseca S; Balanzategui A; Justica B; Orfao A Haematologica; 2003 Aug; 88(8):874-87. PubMed ID: 12935975 [TBL] [Abstract][Full Text] [Related]
40. Subcutaneous panniculitis-like T-cell lymphoma: a clinicopathologic, immunophenotypic, and molecular study of 22 Asian cases according to WHO-EORTC classification. Kong YY; Dai B; Kong JC; Zhou XY; Lu HF; Shen L; Du X; Shi DR Am J Surg Pathol; 2008 Oct; 32(10):1495-502. PubMed ID: 18708940 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]